• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国海南恶性疟原虫对氯喹耐药性的变化

Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China.

作者信息

Liu D Q, Liu R J, Ren D X, Gao D Q, Zhang C Y, Qui C P, Cai X Z, Ling C F, Song A H, Tang X

机构信息

Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, Shanghai.

出版信息

Bull World Health Organ. 1995;73(4):483-6.

PMID:7554020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2486789/
Abstract

In 1979, in view of the widespread resistance of Plasmodium falciparum to chloroquine in the island of Hainan, China, it use as an antimalarial was suspended throughout the island. A longitudinal survey of the chloroquine-sensitivity of P. falciparum was carried out over the period 1981-91 to investigate whether its resistance had changed from the 1979 level. In-vitro assays were carried out every 2-3 years, while in-vivo tests were performed annually over the period 1981-83 and also in 1991. Resistance to chloroquine declined progressively after its use had stopped. The in-vitro tests indicated that the rate of chloroquine-resistant P. falciparum was 97.9% in 1981, but dropped to 60.9% in 1991 (P < 0.001). The mean concentration of chloroquine for complete inhibition of schizont formation was 10.4 pmol/microliters in 1981, but decreased to 3.0 pmol/microliters in 1991 (P < 0.001). The proportion of samples taken from malaria cases that required high concentrations ( > 6.4 pmol/microliters) of chloroquine for complete inhibition of schizont formation was 83.3% in 1981, but only 17.4% in 1991 (P < 0.001); at low concentrations ( > 1.6 pmol/microliters), the corresponding proportions increased from 4.2% in 1981 to 60.8% in 1991 (P < 0.001). In the 4-week in-vivo test, the rate of chloroquine-resistant P. falciparum decreased from 84.2% in 1981 to 40% in 1991 (P < 0.001). RII + RIII cases represented 59.4% of the total resistant cases in 1981, but decreased to 37.5% in 1991 (0.02 > P > 0.01).

摘要

1979年,鉴于中国海南岛恶性疟原虫对氯喹的广泛抗性,全岛暂停将氯喹用作抗疟药。1981年至1991年期间,对恶性疟原虫的氯喹敏感性进行了纵向调查,以研究其抗性是否已从1979年的水平发生变化。每2至3年进行一次体外试验,而在1981年至1983年期间以及1991年每年进行体内试验。氯喹停用后,其抗性逐渐下降。体外试验表明,1981年恶性疟原虫对氯喹的抗性率为97.9%,但在1991年降至60.9%(P<0.001)。1981年完全抑制裂殖体形成所需氯喹的平均浓度为10.4 pmol/微升,但在1991年降至3.0 pmol/微升(P<0.001)。从疟疾病例中采集的样本中,完全抑制裂殖体形成需要高浓度(>6.4 pmol/微升)氯喹的比例在1981年为83.3%,但在1991年仅为17.4%(P<0.001);在低浓度(>1.6 pmol/微升)下,相应比例从1981年的4.2%增加到1991年的60.8%(P<0.001)。在为期4周的体内试验中,恶性疟原虫对氯喹的抗性率从1981年的84.2%降至1991年的40%(P<0.001)。RII+RIII病例在1981年占抗性病例总数的59.4%,但在1991年降至37.5%(0.02>P>0.01)。

相似文献

1
Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China.中国海南恶性疟原虫对氯喹耐药性的变化
Bull World Health Organ. 1995;73(4):483-6.
2
[Fluctuation in the resistance of Plasmodium falciparum to chloroquine in China].
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Feb 28;23(1):27-31.
3
[Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years].
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1992;10(4):241-4.
4
[Changes in chloroquine resistance of Plasmodium falciparum in Hainan province].
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(1):32-4.
5
Sensitivity of Plasmodium falciparum to antimalarial drugs in Hainan Island, China.中国海南岛恶性疟原虫对抗疟药物的敏感性
Korean J Parasitol. 2015 Feb;53(1):35-41. doi: 10.3347/kjp.2015.53.1.35. Epub 2015 Feb 27.
6
The in vivo sensitivity of Plasmodium falciparum to chloroquine in the Red River basin, Yunnan, China.
Southeast Asian J Trop Med Public Health. 1998 Dec;29(4):692-5.
7
[Sensitivity in vivo and in vitro of Plasmodium falciparum to chloroquine and amodiaquine in Bangangte (west Cameroon)].[喀麦隆西部班冈特地区恶性疟原虫对氯喹和氨酚喹的体内外敏感性]
Bull Soc Pathol Exot. 1995 Mar;88(4):149-51.
8
[In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine].[中国-缅甸边境地区恶性疟原虫分离株对氯喹、哌喹和咯萘啶的体外敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012 Feb 29;30(1):41-4.
9
The drug sensitivities of Plasmodium falciparum in the Sonitpur district, Assam, India.印度阿萨姆邦索尼布尔地区恶性疟原虫的药物敏感性
Southeast Asian J Trop Med Public Health. 2005 May;36(3):587-90.
10
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.1990 - 1993年巴布亚新几内亚马当省恶性疟原虫疟疾对阿莫地喹、氯喹和奎宁的耐药性
P N G Med J. 1996 Mar;39(1):16-22.

引用本文的文献

1
Temporal Patterns of Haplotypic and Allelic Diversity Reflect the Changing Selection Landscape of the Malaria Parasite Plasmodium falciparum.单倍型和等位基因多样性的时间模式反映了恶性疟原虫选择格局的变化。
Mol Biol Evol. 2025 Apr 1;42(4). doi: 10.1093/molbev/msaf075.
2
Assessing fitness costs in malaria parasites: a comprehensive review and implications for drug resistance management.评估疟原虫的适合度代价:全面综述及对耐药性管理的启示
Malar J. 2025 Mar 1;24(1):65. doi: 10.1186/s12936-025-05286-w.
3
A review of malaria molecular markers for drug resistance in and in China.中国和东南亚疟疾耐药性分子标志物的研究进展。
Front Cell Infect Microbiol. 2023 May 9;13:1167220. doi: 10.3389/fcimb.2023.1167220. eCollection 2023.
4
Increase in the proportion of Plasmodium falciparum with kelch13 C580Y mutation and decline in pfcrt and pfmdr1 mutant alleles in Papua New Guinea.巴布亚新几内亚恶性疟原虫kelch13 C580Y突变比例增加,pfcrt和pfmdr1突变等位基因比例下降。
Malar J. 2021 Oct 19;20(1):410. doi: 10.1186/s12936-021-03933-6.
5
Surveillance of Plasmodium falciparum pfcrt haplotypes in southwestern uganda by high-resolution melt analysis.高分辨率熔解分析在乌干达西南部监测恶性疟原虫 pfcrt 单倍型。
Malar J. 2021 Feb 25;20(1):114. doi: 10.1186/s12936-021-03657-7.
6
Triple Combination Therapy and Drug Cycling-Tangential Strategies for Countering Artemisinin Resistance.三联组合疗法与药物轮换——应对青蒿素耐药性的相关策略
Curr Infect Dis Rep. 2017 Jul;19(7):25. doi: 10.1007/s11908-017-0579-4.
7
Different patterns of pfcrt and pfmdr1 polymorphism in Plasmodium falciparum isolates from Tehama region, Yemen.也门提哈马地区恶性疟原虫分离株中pfcrt和pfmdr1基因多态性的不同模式
PeerJ. 2016 Jul 12;4:e2191. doi: 10.7717/peerj.2191. eCollection 2016.
8
Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.埃塞俄比亚西北部停用周效磺胺-乙胺嘧啶后恶性疟原虫二氢叶酸还原酶(dhfr)和二氢蝶酸合酶(dhps)突变等位基因的下降趋势
PLoS One. 2015 Oct 2;10(10):e0126943. doi: 10.1371/journal.pone.0126943. eCollection 2015.
9
Evolutionary biology and the avoidance of antimicrobial resistance.进化生物学与抗菌药物耐药性的规避
Evol Appl. 2009 Feb;2(1):40-51. doi: 10.1111/j.1752-4571.2008.00066.x.
10
Surveillance of antimalarial drug resistance in China in the 1980s-1990s.中国 20 世纪 80 年代至 90 年代的抗疟药耐药性监测。
Infect Dis Poverty. 2014 Feb 24;3(1):8. doi: 10.1186/2049-9957-3-8.

本文引用的文献

1
Spread of chloroquine resistance in Plasmodium falciparum.恶性疟原虫对氯喹耐药性的传播。
Parasitol Today. 1987 Aug;3(8):241-6. doi: 10.1016/0169-4758(87)90147-5.
2
[A successive survey on the sensitivity of P. falciparum patients to chloroquine by in vitro microtechnic and in vivo test on Hainan Island].[海南岛恶性疟患者对氯喹敏感性的体外微量技术及体内试验连续观察]
Zhonghua Yu Fang Yi Xue Za Zhi. 1985 Jul;19(4):220-2.
3
Drug-resistant malaria: mechanisms of development and inferences for malaria control.抗药性疟疾:产生机制及对疟疾控制的启示
Trans R Soc Trop Med Hyg. 1990 May-Jun;84(3):323-4. doi: 10.1016/0035-9203(90)90302-u.
4
Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method.培养中的恶性疟原虫:过时红细胞的使用及烛缸法描述
J Parasitol. 1977 Oct;63(5):883-6.
5
Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique.恶性疟原虫的药物敏感性。一种体外微技术。
Lancet. 1978 Jan 7;1(8054):22-3. doi: 10.1016/s0140-6736(78)90365-3.